World Drug Safety Congress Europe was the first strategic pharmacovigilance event to unite a plethora of stakeholders in drug safety, from pharma and biotechs to regulators and patients. The event continues […]

As scientific publications and investment into skin microbiome R&D intensify, there are still fundamental bottlenecks in truly understanding the underlying biology of host-microbiome interactions, standardization of basic research and effective […]